TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)

TELA Bio's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$298000.0 for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 156.9% year-over-year to -$298000.0 in Q1 2026; TTM through Mar 2026 was $25.6 million, a 40.38% decrease from a year earlier, with the FY2025 full-year figure at $25.8 million, down 40.2% from the prior year.
• Cash from Financing Activities slipped to -$298000.0 in Q1 2026 per TELA's latest filing, from $25.8 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $46.4 million in Q2 2023 and bottomed at -$298000.0 in Q1 2026.
• The 5-year median for Cash from Financing Activities is $24000.0 (2025), against an average of $9.2 million.
• Across the five-year window, Cash from Financing Activities slumped 505.56% in 2022 and jumped 194936.36% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$219000.0 in 2022, then surged by 110.05% to $22000.0 in 2023, then soared by 194936.36% to $42.9 million in 2024, then tumbled by 39.77% to $25.8 million in 2025, then tumbled by 101.15% to -$298000.0 in 2026.
• Per Business Quant, the three latest TELA Cash from Financing Activities figures stand at -$298000.0 (Q1 2026), $25.8 million (Q4 2025), and $24000.0 (Q3 2025).